美国感染病学会抗菌药物管理卓越中心认定项目介绍
美国感染病学会(IDSA)基于抗菌药物管理(AMS)倡导经验,推出AMS卓越中心(CoE)认定项目,旨在分享最佳实践并为其他医院树立标准。文中描述了认定流程与目的,指出CoE机构持续提供高质量诊疗、作为执行新型AMS原则的「金标准」并展现对ASP的承诺。
要点
- IDSA设立AMS卓越中心认定以推广最佳实践并树立标准
- CoE认定代表机构持续提供高质量诊疗并作为AMS金标准
- 该认定旨在提升临床医生对IDSA相关机会的认知
核心结论
- IDSA的AMS CoE项目将作为分享最佳实践和展示其他医院应达标准的渠道,以推进AMS领域。
研究设计与样本
- 本文为描述性文章,介绍IDSA设立AMS卓越中心认定的流程、目的及项目演变。
主要发现
- CoE认定表明机构持续提供高质量诊疗、作为执行新型AMS原则的金标准并展现对ASP的承诺。
关键数值与推荐
- CDC和WHO推荐ASP,Joint Commission要求实施ASP以遏制抗菌药物耐药。
- 原文指出不足50%的机构已建立最优ASP。
临床怎么用
- 临床医生可通过IDSA的CoE认定了解可获得的AMS相关机会。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Antimicrobial stewardship programs (ASPs) are recommended by the Centers for Disease Control and Prevention and World Health Organization and mandated by the Joint Commission to curb antimicrobial resistance. However, <50% of institutions have optimal ASPs in place. Building on its experience of antimicrobial stewardship (AMS) advocacy, the Infectious Diseases Society of America (IDSA) developed the AMS Centers of Excellence (CoE) program, which will serve as a conduit to share best practices and highlight the standards for other hospitals to achieve in order to advance the field of AMS. A designation of CoE signifies that these institutions deliver high-quality care consistently, serve as the "gold" standard for executing novel AMS principles, and demonstrate commitment to their ASP. Here, we describe the process and purpose of designating institutions as AMS CoEs, provide awareness to clinicians on opportunities available through IDSA with this CoE designation, and discuss the evolution of the program.
引用
- Kullar R, Nagel J, Bleasdale SC, et al. Going for the Gold: A Description of the Centers of Excellence Designation by the Infectious Diseases Society of America. Clin Infect Dis. 2019. PMID: 30239608. doi:10.1093/cid/ciy797
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。